Emcure Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹1,288.65(10.00%)May 23, 2025 15:29:48 PM IST
- NSE
- BSE
- Vol : 364.13K (NSE + BSE)Last 20 day avg : 129.00 K
Emcure Pharmaceuticals is trading 10.00% upper at Rs 1,288.65 as compared to its last closing price. Emcure Pharmaceuticals has been trading in the price range of 1,288.65 & 1,202.10. Emcure Pharmaceuticals has given -19.31% in this year & 9.59% in the last 5 days. Emcure Pharmaceuticals has TTM P/E ratio 45.53 as compared to the sector P/E of 25.03.There are 3 analysts who have initiated coverage on Emcure Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 153.72 Crores in its last quarter.Listed peers of Emcure Pharmaceuticals include Ola Electric Mobility (2.74%), Sagility India (-2.59%), Emcure Pharmaceuticals (10.00%).The Mutual Fund holding in Emcure Pharmaceuticals was at 2.73% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Emcure Pharmaceuticals was at 3.06% in 31 Mar 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on May 23, 2025, 08:49 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/B7.48The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values36.74Price-to-earnings ratio based on trailing 12-month earnings
- Debt To EquityHigher than industry0.79The debt-to-equity ratio, indicating a company's financial leverage.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable
The company has grown its December quarter profit by 35.49% from Rs 113.45 crore to Rs 153.72 crore, year-on-year- The debt to equity of the company is higher than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 1,151.80
- R2
- 1,281.80
- R3
- 1,382.70
- S1
- 920.90
- S2
- 820.00
- S3
- 690.00
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Ola Electric Mobility | Neutral | 52.91 | 2.74 | 23,337.70 | - | 4.98 | - | 65.30 |
| Sagility India | Bearish | 42.47 | -2.59 | 19,827.03 | 37.80 | 2.48 | - | 12.28 |
| Emcure Pharmaceuticals | Bullish | 1,288.65 | 10.00 | 24,417.77 | 40.59 | 6.88 | - | 33.27 |
| Five Star Business Finance | Moderately Bearish | 696.50 | 1.35 | 20,483.56 | 17.39 | 3.15 | 0.30 | 125.65 |
| Onesource Specialty Pharma | Neutral | 1,682.40 | 0.99 | 19,206.03 | 337.95 | 3.27 | - | 6.50 |
- Pledged found - Promoter(s) have pledged 0.04% of shares.
- Promoter(s) have increased pledged shares to 0.00% from 0.04% earlier.
- Promoter(s) holds a high stake in the company at 77.92%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has increased by 0.01 percentage points from previous quarter
- Mutual Funds holding has decreased by 0.37 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
- Industry
- ISININE168P01015
- BSE Code544210
- NSE CodeEMCURE
Emcure Pharmaceuticals is trading at 1288.65 as on Fri May 23 2025 09:59:48. This is 10.00% upper as compared to its previous closing price of 1171.50.
The market capitalization of Emcure Pharmaceuticals is 24417.77 Cr as on Fri May 23 2025 09:59:48.
The average broker rating on Emcure Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Emcure Pharmaceuticals is 1577.50 whereas the 52 wk low is 890.00
Emcure Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 45.53
- Sector P/E: 25.03
- Dividend Yield: 0.00%
- D/E ratio: -
Emcure Pharmaceuticals reported a net profit of 498.18 Cr in 2024.
The Mutual Fund Shareholding was 2.73% at the end of 31 Mar 2025.